|
Re: Zacks SCR Resverlogix Report 11/5/18; Apabetalone: The Last Mile
|
2
|
Resverlogix Corp.
|
Nov 06, 2018 05:59PM
|
|
Re: Epizyme market cap $750 mil USd
|
2
|
Zenith Epigenetics
|
Jun 15, 2017 11:21PM
|
|
Re: Bioasis Announces Sale of Royalty Interest in LSD Enzymes Being Developed Under the Chiesi Group–Bioasis Strategic Alliance to XOMA Corporation
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 04, 2020 05:33PM
|
|
Re: If we follow AMRN's pattern...
|
2
|
Resverlogix Corp.
|
Aug 08, 2019 09:46PM
|
|
Jardiance EMPA-REG OUTCOME trial as model for BETonMACE
|
2
|
Resverlogix Corp.
|
Aug 31, 2015 01:27PM
|
|
Re: A new blog post with RVX mentioned....
|
2
|
Resverlogix Corp.
|
Jul 18, 2016 02:36PM
|
|
Re: 2019 Potential Events
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 10:12PM
|
|
Re: Current Status of Draft Checklist... thumbs up...!
|
2
|
Resverlogix Corp.
|
Jul 28, 2016 12:32PM
|
|
Re: Patient Years & MACE rate Question
|
2
|
Resverlogix Corp.
|
Jul 11, 2019 10:04AM
|
|
Re: Has Kenneth Lebioda done presentations before?
|
2
|
Resverlogix Corp.
|
Sep 22, 2017 07:03AM
|
|
Re: AACR 2018
|
2
|
Zenith Epigenetics
|
Mar 05, 2018 11:08PM
|
|
BETting on a new heart failure treatment
|
2
|
Resverlogix Corp.
|
May 18, 2017 11:31AM
|
|
Re: Sparks Therapeutics Gene Therapy Deal
|
2
|
Resverlogix Corp.
|
Feb 24, 2019 07:23AM
|
|
Re: Looks like Top SoC for Diabetes is evolving yet again:
|
2
|
Resverlogix Corp.
|
Jan 17, 2020 09:14PM
|
|
Re: CVOTs on the Horizon
|
2
|
Resverlogix Corp.
|
Oct 01, 2018 04:22PM
|
|
Re: Denali/Sirion deal to get AAVs across the BBB
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jan 09, 2019 03:49PM
|
|
Re: ASCO 2019 coming up May 31 to June 4
|
2
|
Zenith Epigenetics
|
May 22, 2019 02:51PM
|
|
Re: Epigenetics article,...
|
2
|
Resverlogix Corp.
|
Jun 04, 2019 10:53PM
|
|
BIO CEO Schedule Out
|
2
|
Resverlogix Corp.
|
Feb 01, 2019 06:15PM
|
|
Re: Reata, Bardoxolone, NRF2, CKD, Mitochondria, Inflammation, Redox Balance, Reactive Oxygen Species
|
2
|
Resverlogix Corp.
|
Jun 14, 2019 10:04PM
|
